Patents by Inventor Matthew R. Netherton

Matthew R. Netherton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Indol-containing beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions
    Patent number: 7754756
    Abstract: The present invention relates to new beta-agonists of general formula (I) wherein the groups R1 and R2 have the meanings given in the claims and specification, the tautomers, racemates, enantiomers, diastereomers, solvates, hydrates, mixtures thereof, the prodrugs thereof and the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases, methods of preparing these compounds and their use as pharmaceutical compositions.
    Type: Grant
    Filed: October 19, 2006
    Date of Patent: July 13, 2010
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Rainer Walter, Bradford S. Hamilton, Thomas Trieselmann, Matthew R. Netherton, Marco Santagostino, Ingo Konetzki
  • Novel Beta-Agonists, Process for Their Preparation and Their Use as Medicaments
    Publication number: 20080300290
    Abstract: Compounds of general formula (I) which are selective beta-3-agonists and useful for the treatment of obesity and type II diabetes. Exemplary compounds are: [4-(1-{3-[2-(3-phenylsulphonylamino-phenyl)-2-hydroxy-ethylamino]-3-methyl-butyl}-1H-imidazol-4-yl)-phenyl]-acetic acid and methyl [4-(1-{3-[2-(3-phenylsulphonylamino-phenyl)-2-hydroxy-ethylamino]-3-methyl-butyl}-1H-imidazol-4-yl)-phenyl]-acetate.
    Type: Application
    Filed: October 27, 2006
    Publication date: December 4, 2008
    Inventors: Rainer Walter, Thomas Trieselmann, Matthew R. Netherton, Marco Santagostino, Bradford S. Hamilton
  • Novel Beta-Agonists, Method for Producing Them and Their Use as Drugs
    Publication number: 20080269281
    Abstract: Compounds of the formula which are selective beta-3-agonists and useful for the treatment of obesity and type II diabetes. Exemplary compounds are: ethyl 3-{3-[(R)-2-(3-benzenesulphonylamino-phenyl)-2-hydroxy-ethylamino]-3-methyl-butyl}-3H-imidazo[4,5-b]pyridine-5-carboxylate and 3-{3-[(R)-2-(3-benzenesulphonylamino-phenyl)-2-hydroxy-ethylamino]-3-methyl-butyl}-3H-imidazo[4,5-b]pyridine-5-carboxylic acid.
    Type: Application
    Filed: October 27, 2006
    Publication date: October 30, 2008
    Inventors: Thomas Trieselmann, Rainer Walter, Matthew R. Netherton, Bradford S. Hamilton